Benjamin F. Edwards & Company, Inc. Pulmonx Corp Transaction History
Benjamin F. Edwards & Company, Inc.
- $5.69 Billion
- Q2 2024
A detailed history of Benjamin F. Edwards & Company, Inc. transactions in Pulmonx Corp stock. As of the latest transaction made, Benjamin F. Edwards & Company, Inc. holds 50 shares of LUNG stock, worth $148. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50
Previous 50
-0.0%
Holding current value
$148
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding LUNG
# of Institutions
127Shares Held
32.5MCall Options Held
2.6KPut Options Held
216K-
Primecap Management CO Pasadena, CA5.41MShares$16.1 Million0.03% of portfolio
-
Morgan Stanley New York, NY3.49MShares$10.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$7.92 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$6.78 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY1.89MShares$5.61 Million0.32% of portfolio
About Pulmonx Corp
- Ticker LUNG
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,268,400
- Market Cap $111M
- Description
- Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...